GRK2-Deficiency Reduces Insulin Activation of ERK1/2 and Mitogenesis in Mouse Liver FL83B Cells
The Open Diabetes Journal · 2009
DOI: 10.2174/1876524600902010044 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Diabetes Journal, 2009. Verfasst von Gulnar Shahid und 1 weiteren Autor:innen.
Abstract (Originalsprache)
We have reported that G protein coupled receptor kinase-2 (GRK2) negatively regulates insulin receptor signaling leading to glycogen synthesis in mouse liver derived FL83B cells.Since insulin is a potent cellular growth hormone, present study investigated the effect of GRK2 on insulin-stimulated MAP kinase pathway leading to mitogenesis.Specific GRK2 siRNA was used to knock-down (>90%) GRK2 in FL83B cells.Effect of insulin on ERK1/2 activation and [ 3 H]-methyl thymidine incorporation were determined in GRK2 siRNA-treated and control cells.Insulinstimulated ERK1/2 activation was attenuated in GRK2-deficient as compared to control cells.Basal and insulinstimulated [ 3 H]-methyl thymidine incorporation, a measure of mitogenesis, was lower in GRK2-deficient cells.The data suggest that GRK2 may have positive regulatory role in insulin-stimulated MAP kinase pathway and mitogenesis.The present study together with our earlier report on insulin-induced glycogen synthesis indicates a dual role of GRK2 in insulin receptor signaling/function.
Zitieren
APA
Shahid, G., & Hussain, T. (2009). GRK2-Deficiency Reduces Insulin Activation of ERK1/2 and Mitogenesis in Mouse Liver FL83B Cells. The Open Diabetes Journal. https://doi.org/10.2174/1876524600902010044
Vancouver
Shahid G, Hussain T. GRK2-Deficiency Reduces Insulin Activation of ERK1/2 and Mitogenesis in Mouse Liver FL83B Cells. The Open Diabetes Journal. 2009. doi:10.2174/1876524600902010044
BibTeX
@article{Shahid2009,
author = {Shahid, Gulnar and Hussain, Tahir},
title = {GRK2-Deficiency Reduces Insulin Activation of ERK1/2 and Mitogenesis in Mouse Liver FL83B Cells},
journal = {The Open Diabetes Journal},
year = {2009},
doi = {10.2174/1876524600902010044}
}
EUVIMED